Search results for Multi-Cancer Early Detection S...

Study Reveals Cancer Diagnostic Delays Linked to Population-Based Screening Using Cell-Free DNA Multicancer Early Detect...

A groundbreaking investigation into the ramifications of population-based multicancer early detection (MCED) screening trials has shed new light on the nuanced interplay between en...

Amplified Sciences Initiates Patient Enrollment for PanAMP Multicenter Real-World Clinical Utility Study

Amplified Sciences Unveils PanAMP: A Pioneering Clinical Utility Study Targeting Early Detection of Pancreatic Cancer In a remarkable stride toward advancing early cancer detection...

Simple and Cheap Blood Test Could Detect Cancer and Other Diseases Before Symptoms Appear

MethylScan is a low-cost blood test that detects cancers and organ diseases by analyzing DNA methylation, improving early diagnosis, and identifying disease origin. UCLA researcher...

Low-Cost, Single Sample Blood Test Detects Different Cancers, Liver Disorders, and Other Diseases

Researchers developed a blood test that, in early studies in more than 1,000 people, showed promise as a low-cost method for detecting multiple cancers, various liver conditions, a...

New Blood Test Detects Tumor DNA to Guide Treatment in Advanced Cancer Cases

In a groundbreaking advancement presented at the Congress of the European Society for Radiotherapy and Oncology (ESTRO 2026), researchers have unveiled a promising approach to tail...

Kim Praitano: Why early cancer screening can’t wait

Early detection advances offer new hope for cancer survival rates The post Kim Praitano: Why early cancer screening can’t wait appeared first on Florida Politics - Campaigns &...

New blood test spots four cancers and other diseases by stripping away healthy DNA noise

MethylScan is a new low-cost cell-free DNA methylome test that removes much of the healthy blood DNA background, helping rare disease signals stand out more clearly. In more than 1...

Life Imaging Reviews: What 100,000 Screenings Taught One Founder About Early Detection

In London, heart disease and cancer are public health priorities. Heart and circulatory diseases cause about 170,000 deaths each year in the UK — roughly 1 in 4 deaths, according t...

TRACERx MRD Results Showcase ppmSeq’s Ultra-Sensitive ctDNA Detection at AACR

Ultima Genomics will present ppmSeq MRD data at the AACR Annual Meeting, including TRACERx study findings, demonstrating ultra-sensitive whole-genome ctDNA detection at parts-per-m...

Why We’re Still Finding Cancer Too Late

The truth is there are ways to understand our cancer risk more precisely than we do today, and there are tools to manage it. What’s missing is awareness, access, and a system built...

Su1877 AT-HOME EARLY DETECTION OF PANCREATIC CANCER USING URINARY MIRNAS AND A DIGITAL RISK ASSESSMENT TOOL

Lowering the CA19-9 Cutoff Could Help Detect More High-Risk Pancreatic Cancer Cases

In a groundbreaking advancement poised to reshape the diagnostic landscape for pancreatic ductal adenocarcinoma (PDAC), researchers have unveiled a novel dual-threshold model cente...

How AI Is Spotting Pancreatic Cancer Signals That Most Doctors Miss

A model developed at the Mayo Clinic identified early signs of pancreatic cancer in routine scans more than a year before diagnosis.

Trial of multi-cancer blood test among 142,000 NHS patients fails to meet main aim

Results presented at oncology conference in Chicago show Galleri test failed to reduce late-stage cancer diagnosesA blood test for more than 50 types of cancer that was billed as t...

Strategies for clinicians to catch cancer early in young adults

SAN FRANCISCO — Breast, colorectal and prostate cancers account for most screen-detectable cancers in adults aged under 50 years, with most “unfortunately diagnosed symptomatically...

Cheap Blood Test Might Spot Cancers, Other Diseases

TUESDAY, April 7, 2026 — A simple and cost-effective blood test might be able to help detect multiple cancers and other diseases, a new study says. The test works by analyzing DNA...

'Holy Grail' blood test could prevent one in five cancer deaths - saving 30,000 lives, breakthrough trial suggests

A pioneering blood test that can detect more than 50 cancers before symptoms appear could save tens of thousands of lives a year, promising new research suggests.

Circulating Tumor DNA (ctDNA)

Why Your Doctor Recommends Circulating Tumor DNA (ctDNA)? Everything You Should Know Abstract Tumor cells continuously shed nucleic acid fragments ... Read more The post Circulatin...

Abstract No. LBA15 Liquid Biopsy Detection of TP53, mGSTP1, and mRASS1Fa from Circulating Tumor DNA Improves the Non-inv...

Alpha fetoprotein (AFP) is used to screen high risk patients for hepatocellular carcinoma (HCC) but has limited sensitivity, demanding the identification of new biomarkers. This st...

Why early detection and personalised care are key in cancer treatment

Experts highlight need for cost-effective therapies, wider screening, and precision-led care.

How MRD Testing Is Reshaping Breast Cancer Risk Assessment

New B-59 data shows circulating tumor DNA (ctDNA) and molecular residual disease (MRD) testing can better predict recurrence risk and help guide more personalized care in TNBC.

This compact Chinese device can detect cancer biomarkers in a drop of blood

A single drop of blood could soon be used to screen for early-stage cancer, according to Wen Liaoyong of Westlake University in Hangzhou. Wen’s team has compressed what was once a...

Scientists Discover Blood Biomarker Linked to Cancer Risk in Lynch Syndrome Patients

In a groundbreaking study published in Nature Communications, researchers at The University of Texas MD Anderson Cancer Center have unveiled a novel blood-based biomarker capable o...

AI uses routine data to create biomarker for pancreatic cancer

Approximately a third of patients with pancreatic ductal adenocarcinoma do not have elevated or detectable levels of a biomarker commonly used to measure response to therapy.An AI...